Annual report pursuant to Section 13 and 15(d)

EQUITY TRANSACTIONS (Details - Options exercisable)

v3.22.2
EQUITY TRANSACTIONS (Details - Options exercisable) - Options Held [Member] - $ / shares
12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Stock options outstanding 1,665,948 844,089 51,124
Outstanding Weighted Average Exercise Price $ 2.31 $ 3.07 $ 44.12
Stock options exercisable 267,221 58,954  
Stock options exercisable Weighted Average Exercise Price $ 2.51 $ 20.06  
$1.28 - $1.68 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Stock options outstanding 1,154,114    
Weighted Average Remaining Life (Years) 9 years 4 months 20 days    
Outstanding Weighted Average Exercise Price $ 1.38    
Stock options exercisable 193,526    
Stock options exercisable Weighted Average Exercise Price $ 1.33    
$2.45 - $5.17 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Stock options outstanding 508,654    
Weighted Average Remaining Life (Years) 9 years 1 month 2 days    
Outstanding Weighted Average Exercise Price $ 3.91    
Stock options exercisable 70,515    
Stock options exercisable Weighted Average Exercise Price $ 2.52    
$57.00 - $142.50 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Stock options outstanding 3,180    
Weighted Average Remaining Life (Years) 1 year 5 months 4 days    
Outstanding Weighted Average Exercise Price $ 84.50    
Stock options exercisable 3,180    
Stock options exercisable Weighted Average Exercise Price $ 84.50